Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Advanced Cancer × AZD 6244 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 13 Melanoma 7 Lung Neoplasms 6 Solid Tumours 5 Neoplasms 4 Colorectal Neoplasms 4 Thyroid Neoplasms 3 Neoplasm Metastasis 3 Breast Neoplasms 3 Uveal Melanoma 2 Thyroid Cancer, Papillary 2 Pancreatic Neoplasms 2 Colonic Neoplasms 2 Carcinoma, Hepatocellular 2 Biliary Tract Neoplasms 2 Adult Solid Neoplasm 2 Thyroid Diseases 1 Thymoma 1 Solid Tumors 1 Small Cell Lung Carcinoma 1 Sarcoma 1 Renal Insufficiency 1 Rectal Neoplasms 1 Non-small Cell Lung Cancer Metastatic 1 Neurofibrosarcoma 1 Neurofibromatosis 1 1 Neuroblastoma 1 Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1 Locally Advanced or Metastatic Solid Tumors 1

Interventions

Nivolumab 10 Surveys and Questionnaires 6 Bevacizumab 5 linrodostat 4 Standard of Care 4 Ipilimumab 4 Interviews as Topic 4 Docetaxel 4 temsirolimus 3 Sirolimus 3 Pemetrexed 3 Paclitaxel 3 Gemcitabine 3 Erlotinib Hydrochloride 3 Cetuximab 3 ARRY-334543 3 relatlimab 2 regorafenib 2 abemaciclib 2 Vorinostat 2 Trastuzumab 2 Sorafenib 2 N-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamide 2 Magnetic Resonance Spectroscopy 2 Carboplatin 2 vorolanib 1 vistusertib 1 trametinib 1 tislelizumab 1 sargramostim 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00085787 2020-10-14

A Study of ARRY-142886 in Patients With Advanced Cancer

Array BioPharma

Phase 1 Completed

Advanced Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡